Genome sequencing in a case of Niemann–Pick type C

  1. Desiree A. Marshall5
  1. 1University of Washington School of Medicine, Seattle, Washington 98195, USA;
  2. 2Medical Scientist Training Program (MSTP), University of Washington, Seattle, Washington 98195, USA;
  3. 3Department of Genome Sciences, University of Washington, Seattle, Washington 98105, USA;
  4. 4Howard Hughes Medical Institute, Seattle, Washington 98195, USA;
  5. 5Department of Pathology, University of Washington, Seattle, Washington 98195, USA;
  6. 6Department of Neurology, University of Washington, Seattle, Washington 98105, USA;
  7. 7Department of Medicine, University of Washington, Seattle, Washington 98195, USA
  1. Corresponding authors: horwitz{at}uw.edu; damarsh{at}uw.edu
  1. 8 These authors contributed equally to this work.

Abstract

Adult-onset Niemann–Pick disease type C (NPC) is an infrequent presentation of a rare neurovisceral lysosomal lipid storage disorder caused by autosomal recessive mutations in NPC1 (∼95%) or NPC2 (∼5%). Our patient was diagnosed at age 33 when he presented with a 10-yr history of difficulties in judgment, concentration, speech, and coordination. A history of transient neonatal jaundice and splenomegaly with bone marrow biopsy suggesting a lipid storage disorder pointed to NPC; biochemical (“variant” level cholesterol esterification) and ultrastructural studies in adulthood confirmed the diagnosis. Genetic testing revealed two different missense mutations in the NPC1 gene—V950M and N1156S. Symptoms progressed over >20 yr to severe ataxia and spasticity, dementia, and dysphagia with aspiration leading to death. Brain autopsy revealed mild atrophy of the cerebrum and cerebellum. Microscopic examination showed diffuse gray matter deposition of balloon neurons, mild white matter loss, extensive cerebellar Purkinje cell loss with numerous “empty baskets,” and neurofibrillary tangles predominantly in the hippocampal formation and transentorhinal cortex. We performed whole-genome sequencing to examine whether the patient harbored variants outside of the NPC1 locus that could have contributed to his late-onset phenotype. We focused analysis on genetic modifiers in pathways related to lipid metabolism, longevity, and neurodegenerative disease. We identified no rare coding variants in any of the pathways examined nor was the patient enriched for genome-wide association study (GWAS) single-nucleotide polymorphisms (SNPs) associated with longevity or altered lipid metabolism. In light of these findings, this case provides support for the V950M variant being sufficient for adult-onset NPC disease.

Footnotes

  • [Supplemental material is available for this article.]

  • Received May 26, 2016.
  • Accepted September 6, 2016.

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.

| Table of Contents